English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'

Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'

Patient Daily | Apr 14, 2025

UTHealth Houston unveils new master’s program in cognitive and behavioral sciences

Patient Daily | Apr 14, 2025

Allergists emphasize awareness month for managing allergic asthma in the U.S

Patient Daily | Apr 11, 2025

UTHealth Houston schools rank first in Texas by U.S. News & World Report

Patient Daily | Apr 10, 2025

Researchers uncover mechanisms behind metabolic demands in nursing mothers

Patient Daily | Apr 10, 2025

House budget plan targeting Medicaid, clean air programs faces opposition

Patient Daily | Apr 10, 2025

American Lung Association honors Senator Murkowski and Representative Kelly for lung health advocacy

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access

  • « First
  • «
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily